| Literature DB >> 25284222 |
Alban Ordureau1, Shireen A Sarraf1, David M Duda2, Jin-Mi Heo1, Mark P Jedrychowski1, Vladislav O Sviderskiy2, Jennifer L Olszewski2, James T Koerber3, Tiao Xie4, Sean A Beausoleil5, James A Wells3, Steven P Gygi1, Brenda A Schulman2, J Wade Harper6.
Abstract
Phosphorylation is often used to promote protein ubiquitylation, yet we rarely understand quantitatively how ligase activation and ubiquitin (UB) chain assembly are integrated with phosphoregulation. Here we employ quantitative proteomics and live-cell imaging to dissect individual steps in the PINK1 kinase-PARKIN UB ligase mitochondrial control pathway disrupted in Parkinson's disease. PINK1 plays a dual role by phosphorylating PARKIN on its UB-like domain and poly-UB chains on mitochondria. PARKIN activation by PINK1 produces canonical and noncanonical UB chains on mitochondria, and PARKIN-dependent chain assembly is required for accumulation of poly-phospho-UB (poly-p-UB) on mitochondria. In vitro, PINK1 directly activates PARKIN's ability to assemble canonical and noncanonical UB chains and promotes association of PARKIN with both p-UB and poly-p-UB. Our data reveal a feedforward mechanism that explains how PINK1 phosphorylation of both PARKIN and poly-UB chains synthesized by PARKIN drives a program of PARKIN recruitment and mitochondrial ubiquitylation in response to mitochondrial damage.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25284222 PMCID: PMC4254048 DOI: 10.1016/j.molcel.2014.09.007
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970